Most patients with cystic fibrosis may receive insufficient antibiotics to fight lung infections: Real-time tracking of serum antibiotic concentrations could help recovery from pulmonary exacerbations

The majority of patients with cystic fibrosis may not achieve blood concentrations of antibiotics sufficiently high enough to effectively fight

What would help or hinder patient participation in mitochondrial disease clinical trials? Patient-centric perspective offers key insights into upcoming treatment studies

As clinical trials gear up with the aim of attaining the first FDA-approved treatments for mitochondrial disease, a new study